[Federal Register Volume 71, Number 87 (Friday, May 5, 2006)]
[Notices]
[Pages 26480-26481]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-6801]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Navy


Notice of Availability of Government-Owned Inventions; Available 
for Licensing

AGENCY: Department of the Navy, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of the Navy hereby gives notice of the 
availability of exclusive or partially exclusive licenses to practice 
worldwide under the following pending patents. Any license granted 
shall comply with 35 U.S.C. 209 and 37 CFR part 404. Applications will 
be evaluated utilizing the following criteria: Ability to manufacture 
and market the technology; manufacturing and marketing ability; time 
required to bring technology to market and production rate; royalties; 
technical capabilities; and small business status.
    U.S. Patent application Serial Numbers 11/328,486 and PCT/US2006/
00194 entitled, ``Method for the detection of stress biomarkers 
including cortisol by fluorescence polarization'' filed on January 4, 
2006. The invention relates to a competitive a fluorescence method for 
estimating the concentration of stress biomarkers such as cortisol, 
melatonin and secretory IgA, in bodily fluids including serum, urine 
and oral fluids including saliva.
    U.S. Patent application Serial Number 11/373,777 entitled ``Methods 
for Downregulating Expression of an HIV-1 Cofactor'' filed on March 10, 
2006. The present invention relates to a method of inducing a decrease 
in HIV-1 susceptibility in CD4 T cells. The method contemplates the 
induction of the HIV-1 decrease in susceptibility by treating CD4 T 
cells by blocking intra-cellular signaling via CTLA-4.
    U.S. Patent application Serial Numbers 11/357,462 and PCT/US06/
04620, entitled ``Diagnostic Assay for Orientia Tsutsugamushi by 
Detection of Responsive Gene Expression'' filed on February 9, 2005. 
The present invention relates to a method of diagnosing Rickettsial 
diseases by analysis of modulation of host gene expression. The method 
contemplates the use of microarray technology for the detection and 
analysis of gene up or down regulation in response to bacterial 
infection.
    U.S. Patent application Serial Number 60/762,559 entitled ``Interim 
Dental Dressing and Restorative Material'' filed on January 25, 2006. 
The present invention relates to a restorative dental formulation for 
the temporary replacement of tooth structure and missing dental 
restorations. The invention also relates to the packaging of the dental 
formulation into single-use disposable containers for easy admixing of 
contents, easy and accurate determination of proper admixing of 
ingredients and easy and effective dispensing of restorative material.
    U.S. Patent application Serial Number 60/781,407 entitled ``Method 
for the Detection of Target Molecules by Fluorescence Polarization 
Using Peptide Mimics'' filed on March 10, 2006. The invention relates 
to a competitive method measuring stress biomarkers including cortisol, 
melatonin and secretory IgA by fluorescence polarization,fluorescence 
life-time analysis or fluorescence resonance energy transfer. The 
method can be carried out using samples from a wide range of fluid 
samples including serum and oral fluids including saliva.
    U.S. Patent application Serial Number 60/758,099 entitled 
``Adhesin-Enterotoxin Chimera Based Composition Against 
Enterotoxingenic Escherichia Coli'' filed on January 11, 2006. The 
invention relates to a method of inducing an immune response against 
enterotoxigenic Escherichia coli using a chimera composed of bacterial 
fimbriae components and immunogenic bacterial toxins. The inventive 
composition contemplates Escherichia coli adhesin molecularly fused to 
diarrheagenic bacteria toxin yielding an adhesin-toxoid chimera.

DATES: Applications for a non-exclusive, exclusive or partially 
exclusive license may be submitted at any time from the date of this 
notice.

ADDRESSES: Submit application to the Office of Technology Transfer, 
Naval

[[Page 26481]]

Medical Research Center, 503 Robert Grant Ave, Silver Spring, MD 20910-
7500.

FOR FURTHER INFORMATION CONTACT: Dr. Charles Schlagel, Director, Office 
of Technology Transfer, Naval Medical Research Center, 503 Robert Grant 
Ave, Silver Spring, MD 20910-7500, telephone 301-319-7428, or E-Mail: 
[email protected].

    Dated: April 28, 2006.
Eric McDonald,
Lieutenant Commander, Judge Advocate General's Corps, U.S. Navy, 
Federal Register Liaison Officer.
 [FR Doc. E6-6801 Filed 5-4-06; 8:45 am]
BILLING CODE 3810-FF-P